Global /Canada /Financial Services /Financial Conglomerates /NTLX
chevron_leftBack
Neurothera Labs Inc. logo

Neurothera Labs Inc.

NTLX
TSXV: NTLX Delayed
0.2600CAD 0%
0.1863 USD
As of 13 June 2026, Neurothera Labs Inc. has a market cap of $2.68M USD, ranking #46476 globally and #2338 in Canada. It ranks #4611 in the Financial Services sector, and #850 in the Financial Conglomerates industry.
Global Rank
46476
Country Rank
2338
Sector Rank
4611
Industry Rank
850
Key Stats
Market Cap
$2.68MUSD
3.75M CAD
Enterprise Value
$15.75MUSD
21.98M CAD
Company Profile
Country (HQ)
Sector
Financial Services
Industry
Financial Conglomerates
CEO
Oz Adler open_in_new
Website
neurothera.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 63% 30% 53% 73% 73%

News

Loading...

Markets

Exchange Ticker Price
TSX Venture Exchange
MIC: XTSX
PRIMARY
NTLX
ISIN: CA64136J1012
Shares Out.:
20.848M1 Shares Float: 4.858M2
TV:
SA:
YF:
GF:
BA:
MS:
0.2600 CAD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Neurothera Labs Inc.

Neurothera Labs Inc. operates a clinical-stage pharmaceutical company. The company engages in the drug development programs based on THC and/or non-psychoactive CBD: SCI-110 for the treatment of Tourette syndrome, for the treatment of Alzheimer's disease and agitation; and SCI- 210 for the treatment of ASD and status epilepticus. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Vancouver, Canada. As of February 23, 2023, Neurothera Labs Inc. operates as a subsidiary of SciSparc Ltd.

Similar Companies

Industry: Financial Conglomerates (Canada)
Name
Market Cap diff.
PE
ONEX
$6.17B
8.63B CAD
230K%
9.3
$781.87M
29K%
708.4
$641.08M
896.19M CAD
24K%
6.0
$606.94M
848.46M CAD
23K%
-
$321.61M
12K%
-
$321.34M
12K%
40.6
Industry: Financial Conglomerates (Global)
Name
Market Cap diff.
PE
INVE-A
$120.04B
1.14T SEK
4M%
5.9
402340
$71.97B
109.46T KRW
3M%
12.5
ITSA3
$30.93B
157.1B BRL
1M%
9.5
$21.94B
207.94B SEK
817K%
5.2
$18.94B
598.03B TWD
705K%
12.6
HAL
$17.79B
15.4B EUR
663K%
9.6
chevron_leftBack